Nadine Godsman1, Michael Kohlhaas2, Alexander Nickel2, Lesley Cheyne1, Marco Mingarelli3, Lutz Schweiger4, Claire Hepburn1, Chantal Munts5, Andy Welch3, Mirela Delibegovic1, Marc Van Bilsen5, Christoph Maack2, Dana K Dawson1. 1. Aberdeen Cardiovascular and Diabetes Centre, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen AB25 2ZD, UK. 2. Comprehensive Heart Failure Center (CHFC), Würzburg, Deutsches Zentrum für Herzinsuffizienz Würzburg, Universitätsklinikum Würzburg, Am Schwarzenberg 15, Haus A15, 97078 Würzburg, Germany. 3. Biomedical Physics, University of Aberdeen, Aberdeen AB25 2ZD, UK. 4. John Mallard Scottish P.E.T. Centre, University of Aberdeen, Aberdeen AB25 2ZD, UK. 5. School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences - Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, Netherlands.
Abstract
AIMS: Cardiac energetic impairment is a major finding in takotsubo patients. We investigate specific metabolic adaptations to direct future therapies. METHODS AND RESULTS: An isoprenaline-injection female rat model (vs. sham) was studied at Day 3; recovery assessed at Day 7. Substrate uptake, metabolism, inflammation, and remodelling were investigated by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography, metabolomics, quantitative PCR, and western blot (WB). Isolated cardiomyocytes were patch-clamped during stress protocols for redox states of NAD(P)H/FAD or [Ca2+]c, [Ca2+]m, and sarcomere length. Mitochondrial respiration was assessed by seahorse/Clark electrode (glycolytic and β-oxidation substrates). Cardiac 18F-FDG metabolic rate was increased in takotsubo (P = 0.006), as was the expression of GLUT4-RNA/GLUT1/HK2-RNA and HK activity (all P < 0.05), with concomitant accumulation of glucose- and fructose-6-phosphates (P > 0.0001). Both lactate and pyruvate were lower (P < 0.05) despite increases in LDH-RNA and PDH (P < 0.05 both). β-Oxidation enzymes CPT1b-RNA and 3-ketoacyl-CoA thiolase were increased (P < 0.01) but malonyl-CoA (CPT-1 regulator) was upregulated (P = 0.01) with decreased fatty acids and acyl-carnitines levels (P = 0.0001-0.02). Krebs cycle intermediates α-ketoglutarate and succinyl-carnitine were reduced (P < 0.05) as was cellular ATP reporter dihydroorotate (P = 0.003). Mitochondrial Ca2+ uptake during high workload was impaired on Day 3 (P < 0.0001), inducing the oxidation of NAD(P)H and FAD (P = 0.03) but resolved by Day 7. There were no differences in mitochondrial respiratory function, sarcomere shortening, or [Ca2+] transients of isolated cardiomyocytes, implying preserved integrity of both mitochondria and cardiomyocyte. Inflammation and remodelling were upregulated-increased CD68-RNA, collagen RNA/protein, and skeletal actin RNA (all P < 0.05). CONCLUSION: Dysregulation of glucose and lipid metabolic pathways with decreases in final glycolytic and β-oxidation metabolites and reduced availability of Krebs intermediates characterizes takotsubo myocardium. The energetic deficit accompanies defective Ca2+ handling, inflammation, and upregulation of remodelling pathways, with the preservation of sarcomeric and mitochondrial integrity.
AIMS: Cardiac energetic impairment is a major finding in takotsubo patients. We investigate specific metabolic adaptations to direct future therapies. METHODS AND RESULTS: An isoprenaline-injection female rat model (vs. sham) was studied at Day 3; recovery assessed at Day 7. Substrate uptake, metabolism, inflammation, and remodelling were investigated by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography, metabolomics, quantitative PCR, and western blot (WB). Isolated cardiomyocytes were patch-clamped during stress protocols for redox states of NAD(P)H/FAD or [Ca2+]c, [Ca2+]m, and sarcomere length. Mitochondrial respiration was assessed by seahorse/Clark electrode (glycolytic and β-oxidation substrates). Cardiac 18F-FDG metabolic rate was increased in takotsubo (P = 0.006), as was the expression of GLUT4-RNA/GLUT1/HK2-RNA and HK activity (all P < 0.05), with concomitant accumulation of glucose- and fructose-6-phosphates (P > 0.0001). Both lactate and pyruvate were lower (P < 0.05) despite increases in LDH-RNA and PDH (P < 0.05 both). β-Oxidation enzymes CPT1b-RNA and 3-ketoacyl-CoA thiolase were increased (P < 0.01) but malonyl-CoA (CPT-1 regulator) was upregulated (P = 0.01) with decreased fatty acids and acyl-carnitines levels (P = 0.0001-0.02). Krebs cycle intermediates α-ketoglutarate and succinyl-carnitine were reduced (P < 0.05) as was cellular ATP reporter dihydroorotate (P = 0.003). Mitochondrial Ca2+ uptake during high workload was impaired on Day 3 (P < 0.0001), inducing the oxidation of NAD(P)H and FAD (P = 0.03) but resolved by Day 7. There were no differences in mitochondrial respiratory function, sarcomere shortening, or [Ca2+] transients of isolated cardiomyocytes, implying preserved integrity of both mitochondria and cardiomyocyte. Inflammation and remodelling were upregulated-increased CD68-RNA, collagen RNA/protein, and skeletal actin RNA (all P < 0.05). CONCLUSION: Dysregulation of glucose and lipid metabolic pathways with decreases in final glycolytic and β-oxidation metabolites and reduced availability of Krebs intermediates characterizes takotsubo myocardium. The energetic deficit accompanies defective Ca2+ handling, inflammation, and upregulation of remodelling pathways, with the preservation of sarcomeric and mitochondrial integrity.
Authors: Thomas Borchert; Daniela Hübscher; Celina I Guessoum; Tuan-Dinh D Lam; Jelena R Ghadri; Isabel N Schellinger; Malte Tiburcy; Norman Y Liaw; Yun Li; Jan Haas; Samuel Sossalla; Mia A Huber; Lukas Cyganek; Claudius Jacobshagen; Ralf Dressel; Uwe Raaz; Viacheslav O Nikolaev; Kaomei Guan; Holger Thiele; Benjamin Meder; Bernd Wollnik; Wolfram-Hubertus Zimmermann; Thomas F Lüscher; Gerd Hasenfuss; Christian Templin; Katrin Streckfuss-Bömeke Journal: J Am Coll Cardiol Date: 2017-08-22 Impact factor: 24.094
Authors: Jennifer Q Kwong; Xiyuan Lu; Robert N Correll; Jennifer A Schwanekamp; Ronald J Vagnozzi; Michelle A Sargent; Allen J York; Jianyi Zhang; Donald M Bers; Jeffery D Molkentin Journal: Cell Rep Date: 2015-06-25 Impact factor: 9.423
Authors: Won Woo Lee; Brett Marinelli; Anja M van der Laan; Brena F Sena; Rostic Gorbatov; Florian Leuschner; Partha Dutta; Yoshiko Iwamoto; Takuya Ueno; Mark P V Begieneman; Hans W M Niessen; Jan J Piek; Claudio Vinegoni; Mikael J Pittet; Filip K Swirski; Ahmed Tawakol; Marcelo Di Carli; Ralph Weissleder; Matthias Nahrendorf Journal: J Am Coll Cardiol Date: 2012-01-10 Impact factor: 24.094
Authors: Trisha Singh; Hilal Khan; David T Gamble; Caroline Scally; David E Newby; Dana Dawson Journal: Circulation Date: 2022-03-28 Impact factor: 29.690
Authors: Ivana Fiserova; Minh Duc Trinh; Moustafa Elkalaf; Lukas Vacek; Marek Heide; Stanislava Martinkova; Kamila Bechynska; Vit Kosek; Jana Hajslova; Ondrej Fiser; Petr Tousek; Jan Polak Journal: Front Cardiovasc Med Date: 2022-08-22